公开(公告)号：EP1311501B1

公开(公告)日：2005-11-02

申请号：EP01961622.6

申请日：2001-08-06

申请人： ELI LILLY AND COMPANY

发明人： BEIGHT, Douglas, Wade ,  MASTERS, JOHN, Joseph ,  SAWYER, Jason, Scott ,  SHUMAN, Robert, Theodore ,  WILEY, Michael, Robert ,  YEE, Ying, Kwong

IPC分类号： C07D403/14 ,  A61K31/4015 ,  A61P7/02 ,  A61P9/10

CPC分类号： C07D401/14 ,  C07D403/12

公开(公告)号：EP1311501A1

公开(公告)日：2003-05-21

申请号：EP01961622.6

申请日：2001-08-06

申请人： ELI LILLY AND COMPANY

发明人： BEIGHT, Douglas, Wade ,  MASTERS, JOHN, Joseph ,  SAWYER, Jason, Scott ,  SHUMAN, Robert, Theodore ,  WILEY, Michael, Robert ,  YEE, Ying, Kwong

IPC分类号： C07D403/14 ,  A61K31/4015 ,  A61P7/02 ,  A61P9/10

CPC分类号： C07D401/14 ,  C07D403/12

摘要： This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositionsthereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.